home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

62.37 -0.43 (-0.68%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

47 48 Next >

Investing Lesson: Value Drivers ↗

November 18, 2023

Trends come, trends go. So, how can investors spot the difference between another passing fad and something with real, sustainable value?

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

November 17, 2023

Via Benzinga

Looking Into DexCom's Recent Short Interest ↗

November 17, 2023

Via Benzinga

Is DexCom the Next Big Growth Stock? ↗

November 17, 2023

It has significant growth drivers in play, but competitors are making inroads too.

Via The Motley Fool

9 Health Care Stocks With Whale Alerts In Today's Session ↗

November 16, 2023

Via Benzinga

Industry Comparison: Evaluating DexCom Against Competitors In Health Care Equipment & Supplies Industry ↗

November 16, 2023

Via Benzinga

Behind the Scenes of DexCom's Latest Options Trends ↗

November 14, 2023

Via Benzinga

This Is What Whales Are Betting On DexCom ↗

November 09, 2023

Via Benzinga

Could DexCom Stock Help You Become a Millionaire? ↗

November 16, 2023

DexCom has achieved strong growth over the years, but there's a big question mark over how strong it will be in the future.

Via The Motley Fool

Dexcom Unveils Portrait Gallery to Portray Emotional Highs and Lows of Living With Diabetes on World Diabetes Day

November 14, 2023

From DexCom, Inc.

Via Business Wire

Novo Nordisk, Eli Lilly Skid — But These Weight-Loss Results Are 'Hard To Ignore' ↗

November 13, 2023

Patients who took Wegovy for five years had a 70% reduced risk of developing diabetes.

Via Investor's Business Daily

10 Health Care Stocks Whale Activity In Today's Session ↗

November 10, 2023

Via Benzinga

In the world of growth stocks, NASDAQ:DXCM shines as a value proposition. ↗

November 09, 2023

NASDAQ:DXCM is not too expensive for the growth it is showing.

Via Chartmill

Check Out What Whales Are Doing With DXCM ↗

November 06, 2023

Via Benzinga

If You Invested $100 In This Stock 10 Years Ago, You Would Have $1,300 Today ↗

November 02, 2023

Via Benzinga

3 Earnings Winners Poised to Outperform the Market ↗

November 09, 2023

Discover three earnings winners that beat estimates and could help you beat the market, too. Which ones will you add to your portfolio?

Via InvestorPlace

10 Health Care Stocks Whale Activity In Today's Session ↗

November 08, 2023

Via Benzinga

2 Medical Device Companies Experiencing Strong Demand Even as Weight-Loss Drugs Rise in Popularity ↗

November 08, 2023

Investors could be making a mistake by selling off these stocks this year.

Via The Motley Fool

3 Healthcare Stocks Getting Help From the Aging Population ↗

November 06, 2023

America's aging population needs chronic conditions treatments, and these healthcare stocks are growing in the quest for healing solutions.

Via InvestorPlace

1 Stock-Split Stock to Buy Hand Over Fist in November, and 1 to Avoid ↗

November 03, 2023

Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there's a phenomenally cheap industry leader, as well as an exceptionally pricey company...

Via The Motley Fool

DexCom Unusual Options Activity ↗

November 01, 2023

Via Benzinga

Analyzing DexCom In Comparison To Competitors In Health Care Equipment & Supplies Industry ↗

November 01, 2023

Via Benzinga

Exploring growth characteristics of DEXCOM INC (NASDAQ:DXCM). ↗

November 01, 2023

High growth, ROE and beating expectations for NASDAQ:DXCM: growth investors may appreciate this.

Via Chartmill

2 Growth Stocks That Could Help Set You Up for Life ↗

November 02, 2023

These businesses have more beneath the surface than what their share prices might indicate.

Via The Motley Fool

Barron's Weekend Stock Picks: Verizon, VF Corp And Altria's Dividend Yield ↗

October 28, 2023

Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read.

Via Benzinga

MedTech Giant DexCom Spotlight Is On G7 US Launch, Analyst Forecasts 22% Revenue Gain In 2024 ↗

October 27, 2023

Oppenheimer analyst Steven Lichtman reiterated the Outperform rating on DexCom, Inc.

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

October 27, 2023

Via Benzinga

Chipotle, Amazon, Deckers Outdoor, Capital One And Other Stocks Move Higher On Friday ↗

October 27, 2023

U.S. stocks traded mixed, with the Nasdaq Composite gaining more than 100 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Why Barnes Group Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

October 27, 2023

Gainers Apollomics, Inc. (NASDAQ: APLM) shares surged 88.4% to $1.07 stoma multiforme with PTPRZ-MET fusion.

Via Benzinga

Why DexCom Inc Stock Is Trading Higher After Earnings ↗

October 27, 2023

DexCom, Inc. (NASDAQ: DXCM) shares are trading higher Friday after the company reported strong third-quarter results and announced a $500 millio

Via Benzinga

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

47 48 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com